Browse By Cell Line Result Page of OvirusTdb

The total number of records retrieved from this search are 15. Click on ID to see further detail.
IDVirus nameVirus strainVirus genome typeVirus familyVirus genome modificationVirus aloneVirus in combination with drug/radiationImmune gene insertion in viral genomeSource of cell lineOrigin of cell lineCell lineConcentration of cell lineIn-vitro toxicityAssayIn-vitro virus concentrationIn-vitro resultModel organismIn-vivo virus concentrationIn-vivo toxicityIn-vivo resultMode of deliveryPathway inducedImmunogenic effectClinical trialPMID
OV_4275AlphavirusM1RNATogaviridaeNoneYesNoNoSICBHuman melanoma cell lineB164000 cells per wellNAMTT assay10 pfu2.19 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_5007Vaccinia virusVG9DNAPoxviridaeNoneYesNoNoATCCMurine melanoma cell lineB161.0E+4 cells per wellNAMTT assay0.1 MOI35% cell viability after 3 daysNoNoNA No responseNANANANA28465492
OV_5008Vaccinia virusVG9DNAPoxviridaeNoneYesNoNoATCCMurine melanoma cell lineB161.0E+4 cells per wellNAMTT assay1 MOI22% cell viability after 3 daysNoNoNA No responseNANANANA28465492
OV_5009Vaccinia virusVG9DNAPoxviridaeNoneYesNoNoATCCMurine melanoma cell lineB161.0E+4 cells per wellNAMTT assay10 MOI20% cell viability after 3 daysNoNoNA No responseNANANANA28465492
OV_5010Vaccinia virusVG9-EGFPDNAPoxviridaeAddition of EGFP gene in tk locusYesNoNoATCCMurine melanoma cell lineB161.0E+4 cells per wellNAMTT assay0.1 MOI36% cell viability after 3 daysNoNoNA No responseNANANANA28465492
OV_5011Vaccinia virusVG9-EGFPDNAPoxviridaeAddition of EGFP gene in tk locusYesNoNoATCCMurine melanoma cell lineB161.0E+4 cells per wellNAMTT assay1 MOI24% cell viability after 3 daysNoNoNA No responseNANANANA28465492
OV_5012Vaccinia virusVG9-EGFPDNAPoxviridaeAddition of EGFP gene in tk locusYesNoNoATCCMurine melanoma cell lineB161.0E+4 cells per wellNAMTT assay10 MOI20% cell viability after 3 daysNoNoNA No responseNANANANA28465492
OV_5013Vaccinia virusWR-EGFPDNAPoxviridaeAddition of EGFP gene in tk locusYesNoNoATCCMurine melanoma cell lineB161.0E+4 cells per wellNAMTT assay0.1 MOI35% cell viability after 3 daysNoNoNA No responseNANANANA28465492
OV_5014Vaccinia virusWR-EGFPDNAPoxviridaeAddition of EGFP gene in tk locusYesNoNoATCCMurine melanoma cell lineB161.0E+4 cells per wellNAMTT assay1 MOI22% cell viability after 3 daysNoNoNA No responseNANANANA28465492
OV_5015Vaccinia virusWR-EGFPDNAPoxviridaeAddition of EGFP gene in tk locusYesNoNoATCCMurine melanoma cell lineB161.0E+4 cells per wellNAMTT assay10 MOI18% cell viability after 3 daysNoNoNA No responseNANANANA28465492
OV_5419Vaccinia virusLIVP-GFPDNAPoxviridaeDeletion mutant for tk geneYesNoNoRussian academy of scienceMurine melanomaB163.0E+3 cells per wellNAMTT assay1 MOI57% cell viability after 24 hoursNoNoNA No responseNAReduction production of IL-6 indicating tumor inhibitionNANA27538520
OV_5420Vaccinia virusLIVP-GFPDNAPoxviridaeDeletion mutant for tk geneYesNoNoRussian academy of scienceMurine melanomaB163.0E+3 cells per wellNAMTT assay1 MOI42% cell viability after 48 hoursNoNoNA No responseNAReduction production of IL-6 indicating tumor inhibitionNANA27538520
OV_5421Vaccinia virusLIVP-GFPDNAPoxviridaeDeletion mutant for tk geneYesNoNoRussian academy of scienceMurine melanomaB163.0E+3 cells per wellNAMTT assay1 MOI22% cell viability after 72 hoursNoNoNA No responseNAReduction production of IL-6 indicating tumor inhibitionNANA27538520
OV_5911Newcastle disease virusNDV-B1RNAParamyxoviridaeNoneYesNoNoATCCHuman melanoma cell lineB16-F105E+5 pfuNALDH release assay0.1 MOI40% cell killing after 3 daysNoNoNA No responseNANAVirus induced IFN-gamma productionNAUS10035984
OV_5913Newcastle disease virusNDV-F3aaRNAParamyxoviridaeVirus expressing NS1 proteinYesNoNoATCCHuman melanoma cell lineB16-F105E+5 pfuNALDH release assay0.1 MOI30% cell killing after 3 daysNoNoNA No responseNANAVirus induced IFN-gamma productionNAUS10035984